PACS Group Reports 38.8% Revenue Growth to $1.28 Billion, Net Income Declines

PACS Group, Inc. reported significant financial performance in its latest quarterly filing, with total revenue reaching $1.28 billion for the three months ended March 31, 2025, a 38.8% increase from $919.8 million in the same period last year. The growth was primarily driven by a substantial rise in patient and resident service revenue, which increased by $357.6 million to $1.28 billion, largely attributed to a 31.2% increase in patient days and a 32.9% increase in operational beds. However, net income decreased to $28.4 million, down 18.5% from $34.8 million in the prior year, reflecting increased operating expenses.

Operating expenses surged by 43.8% to $1.23 billion, influenced by a $287.8 million rise in the cost of services, which included a significant increase in salaries and wages due to the expansion of facilities. General and administrative expenses also saw a notable increase of 110.5%, largely due to legal fees associated with ongoing investigations and stock-based compensation expenses. The company reported a decrease in interest expenses, which fell by 57.1% to $6.9 million, benefiting from reduced debt levels.

PACS Group has been actively expanding its operations, now operating 315 healthcare facilities across 17 states, with a total of 32,309 skilled nursing beds and 2,244 assisted living beds. The company added one new facility during the quarter, contributing 119 skilled nursing beds, and has plans for further expansion, including six additional facilities acquired after the reporting period. The company’s strategy focuses on acquiring underperforming facilities and enhancing their operational performance, which has resulted in a high occupancy rate of 89.2% across its facilities.

Despite the positive growth indicators, PACS Group faces challenges, including ongoing regulatory investigations and a material weakness in internal controls over financial reporting. The company is cooperating with various investigations related to compliance with Medicare and Medicaid regulations and has implemented a remediation plan to strengthen its internal controls. Looking ahead, PACS Group aims to leverage its operational model and expansion strategy to continue driving revenue growth while addressing the challenges posed by regulatory scrutiny and operational complexities.